Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Weitongning Tablets
- Development stage
- Unknown
- Lead developer
- Langzhi Group Shuangren Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Weitongning Tablets are an orally administered pharmaceutical product used for the symptomatic relief of stomach pain, gastric discomfort, and gastritis. The medication is typically a compound formulation that integrates traditional Chinese medicinal (TCM) ingredients with antacid components. Common herbal constituents include *Corydalis yanhusuo* (Yanhusuo), *Paeonia lactiflora* (Baishao), and *Glycyrrhiza uralensis* (Gancao), which provide analgesic and antispasmodic effects by modulating pain receptors and relaxing gastrointestinal smooth muscle. Some formulations also include antacids such as aluminium hydroxide or magnesium carbonate to neutralize excess gastric acid and protect the gastric mucosa. The product is distributed in China by Hunan Shuangren Pharmaceutical, primarily targeting epigastric pain, acid regurgitation, and chronic gastritis.
- Brand names
- Shuangren
- Other names
- 胃痛宁片Weitongning PianWeitongning
02
Targets
MOR (Mu opioid receptor)DRD2 (Dopamine D2 Receptor)
Beyond the preview
Go deeper on Weitongning Tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Weitongning Tablets.